Skip to main content

Table 1 Patient characteristics

From: A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder

Number

Age (years)

Clinical symptoms

PSA (ng/ml)

DRE

Cytology2

Gleason score

Clinical staging

Treatment

Follow-up duration (months)/outcome

1

54

dysuria, frequent micturition (1 month)

11.5

III° enlargement, hard palpable lumps (right)

+

8

T4N1M1b

TURP surgical castration

22/death

2

72

frequent/urgent micturition (3 months)

19.9

II° enlargement, hard, no palpable lump

+

7

T4N1M1b

surgical castration

56/death

3

75

dysuria, frequent micturition (2 years) hematuria (1 month)

55.0

III° enlargement, soft, palpable lump (right)

-

8

T4N1M1b

TURP surgical castration

39/death

4

74

intermittent painless gross hematuria (6 years)

150.0

II° enlargement, hard, palpable lump (left)

-

7

T4N0M0

endocrine therapy chemotherapy

50/survival

51

68

dysuria, frequent/urgent micturition (2 months)

31.7

III° enlargement, soft, no palpable lump

-

-

T4N0M0

TURP surgical castration

23/death

6

70

dysuria, frequent micturition (3 years) hematuria (1 week)

38.9

II° enlargement, hard, palpable lump (right)

+

7

T4N1M1b

surgical castration

40/death

7

58

dysuria, frequent micturition (1 month)

40.5

III° enlargement, hard, no palpable lump

-

7

T4N0M0

TURP surgical castration

30/survival

8

77

frequent/urgent micturition, (1 year)

30.5

III° enlargement, soft, no touchable lump

-

8

T4N1M1b

TURP surgical castration

loss to follow-up

9

69

dysuria frequent/painful micturition (1 year)

29.9

II° enlargement, hard, no palpable lump

-

7

T4N1M1b

surgical castration anti-androgen drug

47/survival

10

78

frequent/urgent micturition (1 year)

75.0

II° enlargement, soft, no touchable lump

-

7

T4N0M0

surgical castration

loss to follow-up

111

80

dysuria, frequent urination (3 years), hematuria (4 days)

13.5

III° enlargement soft no palpable lump

-

-

T4N0M0

TURP endocrine therapy

21/survival

12

71

dysuria, frequent/urgent micturition (6 months)

27.0

III° enlargement, hard, palpable lump (right)

+

8

T4N0M0

TURP surgical castration

loss to follow-up

13

76

intermittent, painless, gross hematuria (1 month)

110.3

IV° enlargement, hard, no palpable lump

+

8

T4N0M0

TURP endocrine therapy

16/survival

14

66

dysuria, frequent/urgent micturition (6 months)

160.0

IV° enlargement, hard, no palpable lump

-

9

T4N0M0

TURP endocrine therapy

12/survival

  1. DRE, digital rectal examination; PSA, prostate-specific antigen; TURP, transurethral resection of the prostate.
  2. 1patients diagnosed with HGPIN;
  3. 2exfoliative urine cytology analysis using acridine orange fluorescence staining has been done three times with the consistent results as shown as follows.
  4. “°” means the degree of the enlargement of prostate.